Literature DB >> 17173442

Modeling the mononuclear, dinuclear, and trinuclear copper(I) reaction centers of copper proteins using pyridylalkylamine ligands connected to 1,3,5-triethylbenzene spacer.

Hiromi Ohi1, Yoshimitsu Tachi, Shinobu Itoh.   

Abstract

The structure and O2-reactivity of copper(I) complexes supported by novel ligands, Pye2 (1,3,5-triethyl-2,4-bis((N-benzyl-N-(2-(pyridin-2-yl)ethyl)-)aminomethyl)benzene), Pye3 (1,3,5-triethyl-2,4,6-tris((N-benzyl-N-(2-(pyridin-2-yl)ethyl))aminomethyl)benzene), MePym2 (1,3,5-triethyl-2,4-bis((N-benzyl-N-(6-methylpyridin-2-ylmethyl))aminomethyl)benzene), and MePym3 (1,3,5-triethyl-2,4,6-tris((N-benzyl-N-(6-methylpyridin-2-ylmethyl))aminomethyl)benzene) have been examined. The ligands are designed to construct mono-, di-, and trinuclear copper(I) complexes by connecting two or three pyridylalkylamine metal-binding sites to a 1,3,5-triethylbenzene spacer. Thus, the reaction of the ligands with [CuI(CH3CN)4]X (X = PF6, CF3SO3) or CuICl gave the expected mononuclear copper(I) complexes [CuI(Pye2)(CF3SO3)] (1) and [CuI(Pye3)](CF3SO3) (2), dinuclear copper(I) complex [CuI2(MePym2)(Cl)]CuICl2 (3), and trinuclear copper(I) complex [CuI3(MePym3)(CH3CN)3](CF3SO3)3 (4), the structures of which were determined by X-ray crystallographic analysis. The mononuclear copper(I) complexes, 1 and 2, exhibit a distorted three-coordinate T-shape structure and a trigonal planar structure, respectively, which are very close to the coordination geometry of the CuA site of PHM (peptidylglycine alpha-hydroxylating monooxygenase) and the CuB site of CcO (cytochrome c oxidase). Notably, 1 and 2 showed a significantly high oxidation potential (990 mV vs SCE), thus showing virtually no reactivity toward O2. On the other hand, the metal centers of the dinuclear and trinuclear copper(I) complexes, 3 and 4, exhibit a distorted trigonal planar geometry and a trigonal pyramidal geometry, respectively. In contrast to the mononuclear copper(I) complexes, these dinuclear and trinuclear copper(I) complexes reacted with O2 to induce an aromatic ligand hydroxylation reaction involving an NIH-shift of one of the ethyl substituents on the benzene spacer. The NIH-shift of the alkyl substituent on the aromatic ring is strong evidence of the electrophilic aromatic substitution mechanism, although the active oxygen intermediate could not be directly detected during the course of the reaction. The biological relevance of the copper(I) complexes is also discussed on the basis of structure and O2-reactivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173442     DOI: 10.1021/ic061509j

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  Synthesis and Characterization of New Trinuclear Copper Complexes.

Authors:  Reza A Ghiladi; Arnold L Rheingold; Maxime A Siegler; Kenneth D Karlin
Journal:  Inorganica Chim Acta       Date:  2012-02-23       Impact factor: 2.545

2.  Molecular oxygen and sulfur reactivity of a cyclotriveratrylene derived trinuclear copper(I) complex.

Authors:  Debabrata Maiti; Julia S Woertink; Reza A Ghiladi; Edward I Solomon; Kenneth D Karlin
Journal:  Inorg Chem       Date:  2009-09-07       Impact factor: 5.165

Review 3.  Copper-Oxygen Complexes Revisited: Structures, Spectroscopy, and Reactivity.

Authors:  Courtney E Elwell; Nicole L Gagnon; Benjamin D Neisen; Debanjan Dhar; Andrew D Spaeth; Gereon M Yee; William B Tolman
Journal:  Chem Rev       Date:  2017-01-19       Impact factor: 60.622

4.  Metal-Templated Ligand Architectures for Trinuclear Chemistry: Tricopper Complexes and Their O2 Reactivity.

Authors:  Davide Lionetti; Michael W Day; Theodor Agapie
Journal:  Chem Sci       Date:  2012-11-26       Impact factor: 9.825

5.  Influence of the spatial distribution of copper sites on the selectivity of the oxygen reduction reaction.

Authors:  N W G Smits; D Rademaker; A I Konovalov; M A Siegler; D G H Hetterscheid
Journal:  Dalton Trans       Date:  2022-01-17       Impact factor: 4.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.